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ABSTRACT 
 
Bronchial asthma is   airway inflammatory, increased hyper reactivity and 
obstructive airway disease 5-10% globally health problem . “Asthma is a chronic 
inflammatory disorder of the airways hyper responsiveness (AHR) that leads to 
recurrent episodes of wheezing, breathlessness, chest tightness and coughing, 
particularly at night or in the early morning. These episodes are usually associated 
with widespread, but variable, airflow obstruction within the lung that is often 
reversible either spontaneously or with treatment”lung volume changes are observed 
by spirometry before and after treatment of homoeopathy. 
 
MAERIALS AND METHODS: 
METHODOLOGY:      Total sample of 30 patients are selected from the Out 
Patient Department, In Patient Department, RHC department of  Sarada Krishna 
Homoeopathic Medical College  Based on inclusive criteria. The patient will be 
categorized 1-30 before treatment, 1A -30A After treatment underwent spirometry. 
The cases were analyzed, evaluated and remedy was prescribed. Assessment was 
done in every one-month and the symptoms were recorded for the pre and posttest 
assessment. ‘Paired t test' was accomplished for the Statistical Analysis. 
RESULT & CONCLUSION: 
Evidently, among the 30 cases under study, 25 cases (87%) shows marked 
improvement, Majority of screened patients in which 20 were Females and 10 were 
males. The common associated complaints are difficulty in breathing, cough almost 
dry, sneezing , obstruction in nose. All the cases were evaluated frequently in 6 
months interval and changes were recorded. The medicines, which are found to be 
more effective, are ARS ALB and NATRUM SULPH. Medicines are more effective 
while they are administered in 50 millesimal potency in frequent dose than dry dose. 
Females are more prone for family history of BA, suppression of skin disease is most 
important factor for development of BA through layers of suppression. This study 
provides an evidence to show that there is significant reduction in the disease 
intensity scores , reduced recurrence of attack and Forced expiratory volume 
markedly increased after administering Homoeopathic Medicines. Hence, we can 
infer that Homoeopathic medicines have a very predominant role in effect to change 
the lung volume capacity in the treatment of bronchial asthma. It is also effective in 
the reducing recurrence of episodes and improved lung volumes also. In addition, the 
results are statistically significant. 
           KEYWORDS: 
Bronchial asthma, forced expiratory volume, vital capacity, forced vital capacity, 
predictive value, Spirometry DisabilityAdjustedLifeYears, American Thoraxic 
Society Standard.  . 
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1. INTRODUCTION 
  
 Asthma is dynamic clinical syndrome of body + mind+ spirit.  Have 
cough, wheezing, tightness of chest, shortness of  breath  intermittent or variable  
more at night called nocturnal asthma. Exaggerated by dust, pollens , allergens, 
occupational, intrinsic factors, diet and stress. 
Among 7.5 billion of world population counted by worldometer, 325 
millions of people are suffered by asthma. “ASTHMA” a greek word meaned   
breathless  or breath on open mouth in adulthood. WHO declared that DALY 
(Disability Adjusted Life Years) lost 15 million/year by asthma , among 
1%globally lost. This is 3 rd commonest cause of death among 10 worldwild. By 
means of extreme pollution, stressful life style modification, poor unhealthy 
modernist diet, unwanted vaccination, drug resistance from childhood onwards 
and more and more suppression.[1][5] 
  In wonderful homoeopathic remedy can give complete rapid  recovery 
from asthma sufferer have very effective changes in bronchospasm and airway 
inflammation,not only equal and also more than that of conventional treatment 
which is proved by lung function test named spirometry.  
SPIROMETERY is device to make measurement of FVC (forced  volume 
capacity-total amount of air blow out in breath), FEV1(Forced expiratory volume 
–Amount of air blow out within mint). TVC (Total volume capacity –ratio 
between FEV1/FVC).This is more specific and more accurate than peak flow 
meter. It moniter  prognosis of asthma.Depend upon the measurement it  lung 
function is classified as normal/restrictive/obstructive /combined by American 
Thoraxic Society Standard.   
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          NEED FOR THE STUDY: 
Asthma is airway inflammatory, hyper sensitivity and obstructive lung 
disease due to allergen, stress, suppression, occupational, seasonal, hereditary as 
etiological  background. From previous researches, it is clear that asthma is 
getting more prevalent and keeping on increasing. Homeopathic constitutional 
remedy can give rapid, effective recovery for asthma in various type successfully. 
CORTICOSTEROID inhalers have user defect, side effects, dependency and high 
expensive to asthma sufferer. To avoid this and  to establish homeopathic 
management in asthma  proved by lung function test, which is non invasive,  in 
expensive and more accurate than peak flow meter called spirometry  which one 
equal and more than that of conventional corticosteroid inhalers.   
Homoeopathy faced criticism in world wide due to high dilution medicine 
and lack of credible clinical evidence. Its important to provide data on modern 
scientific parameter, also should retain the confidence of public. In this study  
gave the evidence of how homoeopathy not only improve the case clinically , but 
also improved on scientific parameter through spirogram in the management of 
BA. 
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                                               2. AIMS AND OBJECTIVES 
 
 
AIMS : 
 
 
spirometry after dynamic  homoeopathic remedy  
 
 
OBJECTIVES: 
 
  know the Homeopathic remedy have equal and more effective than other 
conventional treatment in asthma. 
 
 
prognosis of asthma in its severity and control.    
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REVIEW OF LITERATURE 
 
The respiratory system plays a vital role in the exchange of respiratory gases 
of O2 and CO2 in the human body. It allows for the inhalation of gases such as 
oxygen in the air, transported by the blood around the body to supply tissues and 
cells, and the exhalation of waste gases such as carbon dioxide into the air.  
Respiration can be divided into four major functions: (1) pulmonary 
ventilation, which means the inflow and outflow of air between the atmosphere and 
the lung alveoli (2) diffusion of oxygen and carbon dioxide between the alveoli and 
the blood (3) transport of oxygen and carbon dioxide in the blood and body fluids to 
and from the body’s tissue cells (4) regulation of ventilation and other facets of 
respiration [3].  
Structurally, the respiratory system consists of two parts: The upper 
respiratory system includes the nose, pharynx, and associated structures. The lower 
respiratory system includes the larynx, trachea, bronchi and lungs. The respiratory 
zone consists of tissues within the lungs, where gas exchange occurs. These include 
the respiratory bronchioles, alveolar ducts, alveolar sacs and alveoli. [2] 
3.1. EMBRYOLOGY 
The respiratory system does not carry out its physiological function (of gas 
exchange) until after birth. At about four weeks of development, the respiratory 
system begins as an outgrowth of the foregut just anterior to the pharynx.This 
outgrowth is called the respiratory diverticulum or lung bud.(14) 
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The respiratory system develops from the diverticulam  of the foregut, first as 
midline groove tracheobronchial groove. It has 6 pharyngeal arches. Distal part 
separated from esophagus, cranial part developed as pharynx. Free caudal end become 
bifid each subdivision called lung bud. It forms the bronchi and lung parenchyma. 
Cranial part form larynx and trachea.  2 primary division of the respiratory division 
form right and left principal bronchi. Left division more transverse and divided 2 
lobar bronchioles, rt have 3 lobar bronchioles. Lungs formed by further subdivision of 
lobar bronchi .Totally 17 number of division of each bronchus before birth. 6 more 
after birth . Bronchial tree alveoli formed by expansion of terminal part of tree. Lung 
parenchyma developed from lobar bronchi, separated from mesoderm by connective 
tissue called pleura separated by fissures. IN FETAL LIFE all division Of bronchial 
tree lined by cubical epithelium. It is canalicular phase of lung development. After 
birth alveoli become dilated and lining epithelium become thin. Some cells produce 
surfactant form thin layer of alveoli which reduce surface tension. Alveoli continue to 
multiply until 300 million have formed. This number is reached when the child is 
about 8 years old.[21] 
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3.2. FUNCTIONAL ANATOMY AND PHYSIOLOGY: 
The lungs occupy the upper two-thirds of the bony thorax, bounded medially 
by the spine, the heart and the mediastinum and inferiorly by the diaphragm. During 
breathing, free movement of the lung surface relative to the chest wall is facilitated by 
sliding contact between the parietal and visceral pleura. [13] 
Inspiration involves downward contraction of the dome-shaped diaphragm 
(innervated by the phrenic nerves originating from C3, 4 and 5) and upward, outward 
movement of the ribs on the cost vertebral joints, caused by contraction of the 
external intercostals muscles (innervated by intercostal nerves originating from the 
thoracic spinal cord).[26] 
Expiration is largely passive, driven by elastic recoil of the lungs. The 
conducting airways from the nose to the alveoli connect the external environment 
with the extensive, thin and vulnerable alveolar surface. As air is inhaled through the 
upper airways, it is filtered in the nose, saturated with water vapour; partial recovery 
of this heat and moisture occurs on expiration. Total airway cross-section is smallest 
in the glottis and trachea, making the central airway particularly vulnerable to 
obstruction by foreign bodies and tumors. Normal breath sounds originate mainly 
from the rapid turbulent airflow in the larynx, trachea and main bronchi. The 
multitude of small airways within the lung parenchyma has a very large combined 
cross-sectional area (over 300 cm2 in the third-generation respiratory bronchioles), 
resulting in very slow flow rates. Airflow is normally silent here, and gas transport 
occurs largely by diffusion in the final generations. The acinus is the gas exchange 
unit of the lung and comprises branching respiratory bronchioles and clusters of 
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alveoli. Here the air makes close contact with the blood in the pulmonary capillaries 
(gas-toblood distance < 0.4 µm), and oxygen uptake and CO2 excretion occur.  
The alveoli are lined with flattened epithelial cells (type I pneumocytes) and a 
few, more cuboidal, type II pneumocytes. The latter produce surfactant, which is a 
mixture of phospholipids that reduces surface tension and counteracts the tendency of 
alveoli to collapse under surface tension. Type II pneumocytes can divide to 
reconstitute type I pneumocytes after lung injury. [3], [17] 
 
STRUCTURE OF ALVEOLI 
[3] 
LUNGS: 
The lungs are a pair of respiratory organs situated in the thoracic 
cavity. The right and left lung are separated by mediastinum. The right lung 
weighs about 700g; it is about 50-100g heavier than left lung.
[5]
 Each lung has 
a blunt apex, which projects upward into the neck for about 1in. (2.5cm) above 
the clavicle; a concave base that sits on the diaphragm; a convex costal 
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surface, which corresponds to the concave chest wall; and a concave 
mediastinal surface, which is moulded to the pericardium and other 
mediastinal structures. At about the middle of this surface is the hilum
[6]
 Each 
lung is enclosed and protected by  pleural membrane. The superficial layer, 
called the parietal pleura, lines the wall of the thoracic cavity; the deep layer, 
the visceral pleura, covers the lungs. Between the visceral and parietal pleurae 
is a small space which contains a small amount of lubricating fluid secreted by 
the membranes which reduces friction between the membranes, allowing them 
to slide easily over one another during breathing. 
Lungs are divided into lobes by fissures. Both lungs have an oblique 
fissure, which extends inferiorly and anteriorly; the right lung also has a 
horizontal fissure. The oblique fissure in the left lung separates the superior 
lobe from the inferior lobe. In the right lung, the superior part of the oblique 
fissure separates the superior lobe from the inferior lobe; the inferior part of 
the oblique fissure separates the inferior lobe from the middle lobe, which is 
bordered superiorly by the horizontal fissure. Each lobe receives its own 
secondary (lobar) bronchus. The right primary bronchus gives rise to three 
secondary (lobar) bronchi called the superior, middle, and inferior secondary 
(lobar) bronchi and the left primary bronchus gives rise to superior and 
inferior secondary (lobar) bronchi. Within the lung, the secondary bronchi 
give rise to the tertiary (segmental) bronchi, which are constant in both origin 
and distribution there are 10 tertiary bronchi in each lung. The segment of 
lung tissue that each tertiary bronchus supplies is called a Broncho pulmonary 
segment. Each Broncho pulmonary segment of the lungs has many small 
compartments called lobules; terminal bronchioles subdivide into microscopic 
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branches called respiratory bronchioles. Respiratory bronchioles in turn 
subdivide into several (2–11) alveolar ducts. [2] 
An alveolus is a cup-shaped out pouching lined by simple squamous 
epithelium and supported by a thin elastic basement membrane. The walls of alveoli 
consist of two types of alveolar epithelial cells as type I alveolar cells are simple 
squamous epithelial cells that form a nearly continuous lining of the alveolar wall. 
Type II alveolar cells, also called septal cells, are fewer in number and are found 
between type I alveolar cells. The thin type I alveolar cells are the main sites of gas 
exchange. Type II alveolar cells, rounded or cuboidal epithelial cells with free 
surfaces containing microvilli, secrete alveolar fluid, which keeps the surface between 
the cells and the air moist. 
[2]
, The pulmonary arteries, through their capillary plexus, 
are entirely concerned with alveolar gaseous exchange, while the nutrient supply of 
the lung parenchyma is provided by the bronchial arteries. The pulmonary vein 
tributaries derive partly from the capillaries of the bronchial and the pulmonary 
arteries. The bronchial veins drain the larger bronchi. The lymphatics of the lungs 
drain into the nodes lying at the bifurcations of the larger bronchi, then to the 
tracheobronchial nodes and then into the broncho mediastinal lymph trunk on each 
side. These usually drain directly into the junction of the internal jugular and 
subclavian veins on each side, but may drain, on the right, into the right lymph trunk 
and, on the left, into the thoracic duct. If the subcarinal node is the site of secondary 
deposits it gives the typical bronchoscopic sign of widening of the carina .The 
principal function of the sympathetic (T2-T4) supply to the lung is broncho dilatation, 
while the vagus fibres act as stretch receptors.
[7] 
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Lung mechanics:
 
       Healthy alveolar walls contain a fine network of elastin and 
collagen fibres . The volume of the lungs at the end of a tidal (‘normal’) breath 
out is called the functional residual capacity (FRC). At this volume, the 
inward elastic recoil of the lungs  is balanced by the resistance of the chest 
wall causing negative pressure in the pleural space. Elastin fibres allow  the 
lung to be easily distended at physiological lung volumes, but collagen fibres 
cause increasing stiffness  as full inflation is approached so that, in health, the 
maximum inspiratory volume is limited by the lung .Within the lung, the 
weight of tissue compresses the dependent regions and distends the uppermost 
parts, so a greater portion of an inhaled breath passes to the basal regions, 
which also receive the greatest blood flow as a result of gravity. Elastin fibres 
in alveolar walls maintain small airway patency. Even in health, however, 
these small airways narrow during expiration because they are surrounded by 
alveoli at higher pressure. The volume that can be exhaled is thus limited 
purely by the expiratory muscles to distort the chest wall inwards. 
Control of breathing : 
The respiratory motor neurons in the posterior medulla oblongata are 
the origin of the respiratory cycle.  
• Central chemoreceptors in the ventrolateral  medulla sense the pH of 
the cerebrospinal fluid (CSF) and are indirectly stimulated by a rise in arterial 
PCO2. 
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 • The carotid bodies sense hypoxaemia but are mainly activated by 
arterial PO2 values below 8 KPa (60 mmHg). They are also sensitised to 
hypoxia by raised arterial PCO2.  
• Muscle spindles in the respiratory muscles sense changes in   
  mechanical load .  
 • Vagal sensory fibres from the lung may be stimulated by stretch, by  
                           inhaled  toxins or by disease processes in the interstitium. 
 • Cortical (volitional) and limbic (emotional) influences can override   
  the automatic control of breathing. [16], [17] 
Ventilation/perfusion matching and the pulmonary circulation :  
To achieve optimal gas exchange within the lungs, the regional 
distribution of ventilation and perfusion must be matched. Hypoxia constricts 
pulmonary arterioles and airway CO2 dilates bronchi, helping to maintain 
good regional matching of ventilation and perfusion. The pulmonary 
circulation in health operates at low pressure (approximately 24/9 mmHg). 
Pulmonary hypertension occurs when vessels are destroyed by emphysema, 
obstructed by thrombus, involved in interstitial inflammation or thickened by 
pulmonary vascular disease.  
 
 
 
6 
 
  Lung defences: 
                Upper airway defences: 
 Large airborne particles are trapped by nasal hairs, and smaller 
particles settling on the mucosa are cleared towards the oropharynx by the 
columnar ciliated epithelium which covers the turbinates and septum   
 During cough, expiratory muscle effort against a closed glottis 
results in high intrathoracic pressure, which is then released explosively.  
 The flexible posterior tracheal wall is pushed inwards by the 
high surrounding pressure, which reduces tracheal cross-section and thus 
maximises the airspeed to achieve effective expectoration.  
 The larynx also acts as a sphincter, protecting the airway 
during swallowing and vomiting. 
Lower airway defences: 
 The sterility, structure and function of the lower airways are 
maintained by close cooperation between the innate and adaptive 
immune responses. 
 The innate response in the lungs is characterised  by a number of 
non-specific defence mechanisms.  
 Inhaled particulate matter is trapped in airway mucus and cleared 
by the mucociliary escalator.  
 Airway secretions contain an array of antimicrobial peptides (such 
as defensins, immunoglobulin A (IgA) and lysozyme), 
antiproteinases and antioxidants.  
7 
 
 Many assist with the opsonisation and killing of bacteria, and the 
regulation of the powerful proteolytic enzymes secreted by 
inflammatory cells.  
 In particular, α1antiproteinase (A1Pi) regulates neutrophil 
elastase, and deficiency of this may be associated with premature 
emphysema. 
  Macrophages engulf microbes, organic dusts and other particulate 
matter. They are unable to digest inorganic agents, such as 
asbestos or silica, which lead to their death and the release of 
powerful proteolytic enzymes that cause parenchymal damage. 
  Neutrophil numbers in the airway are low, but the pulmonary 
circulation contains a marginated pool that may be recruited 
rapidly in response to bacterial infection.  
 Adaptive immunity is characterised by the specificity of the 
response and the development of memory. 
  Lung dendritic cells facilitate antigen presentation to T and B 
lymphocytes. 
[3],[2] 
LUNG VOLUMES, CAPACITIES AND ALVEOLAR VENTILATION 
Volume of air taken in and given out 
during normal 
Tidal volume 
Tidal volume calculated by  Inspiratory capacity 
minus inspiratory reserve 
volume 
Tidal Volume in both Men and women 500 ml 
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Pulmonary volumes 
    1.The tidal volume is the volume of air inspired or expired with each normal 
breath; it amounts to about 500 millilitres in the adult male. 
2.The inspiratory reserve volume is the extra volume of air that can be inspired over 
and above the normal tidal volume when the person inspires with full force; it is 
usually equal to about 3000 millilitres. 
Resting tidal ventilation 5 L/min 
Expiratory reserve volume 1000 ml 
Inspiratory reserve volume 3300 ml 
Residual volume 1200 ml 
Inspiratory capacity (TV + IRV) 3800 ml 
Normal vital capacity (TV + IRV + 
ERV) 
4800 ml 
Functional residual capacity (ERV + RV 2200 ml 
Total lung capacity 6000 ml 
Amount of air in lungs at the end of tidal 
breath 
FRC 
Functional residual capacity is Volume remaining of 
normal respiration 
Functional residual capacity ERV + RV= 2.2 L 
Total alveolar volume in litre per minute 4.4 L 
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3.The expiratory reserve volume is the maximum  volume of air that can be expired  
after the end of a normal tidal expiration; this normally amounts to about 1100 
millilitres. 
4.The residual volume is the volume of air remaining in the lungs after the most 
forceful expiration; this volume averages about 1200 millilitres. 
[2]
 
Pulmonary capacities: 
1. The inspiratory capacity equals the tidal volume plus the inspiratory reserve 
volume. This is the amount of air (about 3500 millilitres) a person can breathe 
in, beginning at the normal expiratory level and distending the lungs to the 
maximum amount. 
            The functional residual capacity equals the expiratory reserve volume plus the     
            residual volume. This is the amount of air that remains in the lungs at the end   
          of normal expiration (about 2300 millilitres).  
2. The vital capacity equals the inspiratory reserve volume plus the tidal 
volume plus the expiratory reserve volume 4600 millilitres. 
[16], [17]
 
3. The total lung capacity is the maximum volume to which the lungs can be 
expanded with the greatest possible effort (about 5800 millilitres); it is equal 
to the vital capacity plus the residual volume. 
[2]
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LUNG VOLUMES AND CAPACITY 
BRONCHIALASTHMA 
 
 
Respiratory disease is responsible for a major burden of morbidity and untimely 
death, with conditions such as tuberculosis, pandemic influenza and pneumonia the 
most important in world health terms. The increasing prevalence of allergy, asthma 
and chronic obstructive pulmonary disease (COPD) contributes to the overall burden 
of chronic disease in the community. By 2025, the number of cigarette smokers 
worldwide is anticipated to increase to 1.5 billion, ensuring a growing burden of 
tobacco-related respiratory conditions. Respiratory disease covers a breadth of 
pathologies, including infectious, inflammatory, neoplastic and degenerative 
11 
 
processes. Bronchial asthma is   airway inflammatory, increased hyper reactivity and 
obstructive airway disease 5-10% globally health problem. According to the Global 
Initiative for Asthma Management and prevention (GINA), a definition of Asthma is 
given as; “Asthma is a chronic inflammatory disorder of the airways in which many 
cells and cellular elements play a role.  
The chronic inflammation is associated with airway hyper responsiveness (AHR) that 
leads to recurrent episodes of wheezing, breathlessness, chest tightness and coughing, 
particularly at night or in the early morning. These episodes are usually associated 
with widespread, but variable, airflow obstruction within the lung that is often 
reversible either spontaneously or with treatment” 
 
EPIDIMYOLOGY:  
                 The National Health Interview Survey (NHIS) data on asthma prevalence 
in the United States of America demonstrate an almost doubling of asthma prevalence 
over the last quarter century, from 3.2 percent per 100 population in 1981 to 5.5 
percent per 100 in 1996. One third of those affiliated with asthma are children under 
the age of 18 years. A study conducted in 2006 by Sidney S Burman shows that there 
has been a sharp increase in the global prevalence, morbidity, mortality, and 
economic burden associated with asthma over the last 40 years, particularly in 
children12. Approximately 300 million people worldwide currently have asthma, and 
its prevalence increases by 50% every decade. According to the National Family 
Health Survey-2 report the estimated prevalence of asthma in India is 2468 per 
100,000 persons. The increasing number of hospital admissions for asthma, which are 
most pronounced in young children, reflect an increase in severe asthma, poor disease 
12 
 
management, and poverty. Worldwide, approximately 180,000 deaths annually are 
attributable to asthma, although overall mortality rates have fallen since the 1980s 
[11] [14], [21] 
TYPES    OF ASTHMA: 
 
 
 
 
 
 
 
RISK FACTORS:  
-IgE antibody production against house dust, mites, fungi, 
pollen, animal derived protein.  
 
  
 es[1]  
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ETIOLOGICAL FACTORS: 
Allergens: Allergic asthma is dependent on an IgE response controlled by T and B 
lymphocytes and activated by the interaction of antigen with mast cell–bound IgE 
molecules.  
Pharmacologic Stimuli: The drugs most commonly associated with the Induction of 
acute episodes of asthma are aspirin, coloring agents such as tartrazine, adrenergic 
antagonists, and sulfiting agents. 
Environment and Air Pollution: climatic conditions that promote the concentration 
of atmospheric pollutants and antigens [15]. 
Occupational Factors: acute and chronic airway obstruction have been reported to 
follow exposure to a large number of compounds used in many types of industrial 
processes. 
Infections: Respiratory viruses and not bacteria or allergy to microorganisms are the 
major etiologic factors. In young children, the most important infectious agents are 
respiratory syncytial virus and parainfluenza virus [13        
PATHOGENESIS :  
                 Airway inflammation produced  IgE linked with FcE receptors release mast 
cell protease, histamine and pro inflammatory cytokinase, esinophil produce charcot-
leyden crystals found in sputum,  lymphocytes, mast cell, neutrophils more in near 
fatal asthma, occupational asthma leads poor response in corticosteroids. 
Oedema,hypertrophy of smooth muscle leads airway remodeling. Thickened 
basement membrane, epithelial damage leads creola bodies and curschmanns  spiral 
found in asthma. Mucous plugging, airway hyperreactivity and non-adrenergic non-
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cholinergic nerve defect leads broncho constriction and reversible airway limitation. 
In acute severe asthma leads remodeling, irreversible changes in lung may occur. 
 3.4.2. PATHOPHYSIOLOGY: 
                    The pathophysiologic hallmark of asthma is a reduction in airway 
diameter brought about by contraction of smooth muscle, vascular congestion, edema 
of the bronchial wall, and thick, tenacious secretions. The net result is an increase in 
airway resistance, a decrease in forced expiratory volumes and flow rates, 
hyperinflation of the lungs and thorax, increased work of breathing, alterations in 
respiratory muscle function, changes in elastic recoil, abnormal distribution of both 
ventilation and pulmonary blood flow with mismatched ratios, and altered arterial 
blood gas concentrations. Thus, although asthma is considered to be primarily a 
disease of airways, virtually all aspects of pulmonary function are compromised 
during an acute attack [13]. 
      PATHOLOGICAL CHANGES IN ASTHMA: 
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FEATURES OF BRONCHIAL ASTHMA :  
Asthma is dynamic clinical syndrome of body + mind+ spirit.  Have 
cough, wheezing, tightness of chest, shortness of  breath  intermittent or 
variable  more at night called nocturnal asthma. Exaggerated  by dust, pollens 
, allergens, occupational, intrinsic factors, diet and stress.[4] Asthma is a 
syndrome rather than a condition. It is an episodic disease, with acute 
exacerbations, interspersed with symptom-free periods. Typically most attacks 
are short lived, lasting minutes to hours, and clinically the patient seems to 
recover completely after an attack. However there can be a phase in which the 
patient experiences some degree of airway obstruction daily which is termed 
as chronic asthma. This phase can be mild, with or without superimposed 
severe episodes, or much more serious with severe obstruction persisting for 
days or weeks, the latter condition is known as acute severe asthma. 
[26]
 
       INVESTIGATION :   
  Pulmonary function test-PFM, SPIROMETER. 
  Allergic test-skin prick test 
  Nitric oxide test  
  Arterial blood gas analysis  
 Sputum esinophil 
  Xray chest ,CT  
  bronchoscopy, Laryngoscopy,Positron emission tomography 
  Provacative testing for exercise and cold induced test    
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LUNG FUNCTION TEST: 
Measurements of lung function provide valuable information. 
 Helps to diagnosis 
 Severity of the condition 
 Disease prognosis 
 Regular monitoring in lung function. 
 To  measure the size of the lung 
 Measure the air into and out of the airway 
 Efficiency of lung in process of gas exchange. 
PEAK EXPIRATORY FLOW METERS: Here patient should be instructed to 
record peak flow readings after rising in the morning and before retiring in the 
evening. A diurnal variation (lowest in the morning) of more than 20% is 
considered diagnostic. Normal reading as per mentioned in American lung 
association reveals 80 to 100 L/min as mild level, 50 to 79 L/min as moderate 
level and below 50 L/min as severe level. 
[17]
 Measurement of peak expiratory 
flow rate gives an idea of how narrow or obstructed a person’s airways are by 
measuring the maximum rate at which they can blow air into a peak flow 
meter after a deep breath. 
[7], [9] 
CLASSIFICATION OF ASTHMA : 
[29] 
ICD-1O CC CODE: 
 
- J45.2X 
 – J45.3X 
- J45.4X 
[28]
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–J45.5X 
 Unspecified J45.90x 
♦ X=0 uncomplicated 
♦ X=1 WITH exacerbation 
♦ X= 2 with status 
 
 
MANAGEMENT GOALS: [10] 
  Achieve control of symptoms 
  Reduced asthma mortality  
  Prevent remodeling  
  Restore normal pulmonary function 
  Avoid acute severe asthma /exacerbation  
  Avoid abuse of medication and dependency 
  Achieve best quality of life without limitation  
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Management –non pharmacological level:  
-fish oil in third trimester reduce 
risk of asthma in first 5 yrs of child ,Anti-oxidants ,alpha 3 fatty died ,vit D  
[7] [9] [28]
 
CONVENTIONAL MANAGEMENT: 
 group-beta 2 sympathetic agents 
–ICS (inhaled 
corticosteroid ),LABA. 
 ADVERSE   EFFECTS: 
:[9] [3] 
o Fine tremor o Agitation o Tachycardia/palpitation o Oral  thrush  
o Hoarseness o Suppression of adrenocortical function o Hypertension 
/sodium retention/worsening DM o Gastro esophageal reflex.                                                      
SPIROMETRY:  
          Spirometry is one of lung function test to monitor how the lung is work by 
speed of breath and amount of air to inhale and exhale which is affected in Asthma, 
COPD, Cystic fibrosis and bronchiectasis. SPIROMETER is device to make 
measurement of  FVC(forced  volume capacity-total amount of air blow out in 
breath), FEV1(Forced expiratory volume –Amount of air blow out within mint). TVC 
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(Total volume capacity –ratio between FEV1/FVC).This is more specific and more 
accurate than peak flow meter. It moniter  prognosis of asthma. 
[7], [9] 
 SPIROMETRY  
                  measures the amount of air could exhale after a maximum inspiration. 
Blow out into spirometry , this volume is called vital capacity. Amount of air after full 
inspiration is called total lung capacity.  Residual volume is amount of air remaining 
after full expiration. FORCED VITAL CAPACITY is measured after the hard blow 
into spirometry.  VC and FVC are identical in normal lung but in obstructive lung 
disease FVC is less than VC Compression of airway during expiration in BA , COPD. 
VOLUME  in litres in X axis time in second in Y axis. volume of air breathed out in 
first second of forced expiration  called as forced expiration in first second. FEV1 . in 
normal lung FEV 1 is > 70%. In obstructive lungdisease FEVI/ FVC is reduced due to 
prolonged expiration.  In restrictive lung disease FEV1 and FVC reduced in propotion 
of each others , so  ratio is remains normal.   
SPIROMETER 
 
20 
 
SPIROGRAM  NORMAL CURVE :     
 
 INSTRUCTIONS FOLLOWED IN RECORDING A SPIROMETRY: 
[35]
  
 Stand or sit up straight. 
 Make sure the indicator is at the bottom of the meter (zero). 
 Take a deep breath in, filling the lungs completely. 
 Place the mouthpiece in your mouth, lightly bite with your teeth and 
close your lips on it. Be sure your tongue is away from the 
mouthpiece. 
 Blast the air out as hard and as fast as possible in a single blow for 
one mint than followed by deep inspiration. 
 Remove the meter from your mouth. 
 Graf recorded in the screen as per volume of air exhaled in spirometre.  
 Record the number that appears on the meter and then repeat the steps 
two times. 
 Record the highest of the three readings. This reading gives the 
peak expiratory flow (PEFR). 
[7], [9], [28] 
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Spirometry is indicated for the following reasons: 
- To measure bronchial responsiveness in patients suspected of 
having asthma  
- To diagnose and differentiate between obstructive lung disease and 
restrictive lung disease. 
- diagnose the vocal cord dysfunction[17][7],[9]. 
PULMONARY FINDINGS IN ASTHMA 
[23,24]
: 
 
Reduced FVC, Reduced FEV1, FEV1/FVC ratio < 80%, Increase in 
Residual Volume and Total Lung Capacity.  
DIAGNOSTIC CRITERIA FOR ASTHMA: 
CLINICAL FEATURES THE PROBABILITY OF ASTHMA: 
♦ more than one of following symptom like wheezing, 
breathlessness, cough ,tightness of chest.  
♦ More at night and in early morning. 
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♦ Symptoms in response to cold air, allergen, exercise. 
♦ H/O of atopic disorder. 
♦ Widespread wheeze heard while auscultation  
♦ Unexplained peripheral blood eosinophilia. 
   Compatible clinical history  
 plus either/or: 
 • FEV1 ≥ 15%* (and 200 mL) increase
 following administration of a bronchodilator/trial
 of corticosteroids 
 • > 20% diurnal variation on ≥ 3 days
 in a week for 2 weeks on PEF diary  
• FEV1 ≥ 15% decrease after 6 mins of
 exercise. 
Limitation for spirometry: 
 Recent eye surgery 
 Myocardial infarction 
 Abdominal and thoracic surgery 
 Hypertension 
 Smoking recently 
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3.4.6. DIFFERENTIAL DIAGNOSIS FOR ASTHMA: 
Many other conditions can cause symptoms similar to those of 
asthma. In children, other upper airway diseases such as allergic rhinitis and 
sinusitis should be considered as well as other causes of airway obstruction 
including: foreign body aspiration, tracheal stenosis or laryngo-tracheo-
malacia, vascular rings, enlarged lymph nodes or neck masses. In adults, 
COPD, congestive heart failure, airway masses, as well as drug-induced 
coughing due to ACE inhibitors beta blockers, NSAID, steroids aspirin, 
eyedrops should be considered. Chronic obstructive pulmonary disease can 
coexist with asthma and can occur as a complication of chronic asthma 
[16]
. 
3.4.7. PREVENTION: 
 Aggravating factors of bronchial asthma should be avoided which 
includes 
 Limiting or completely avoiding smoking and smoke exposure. 
 Avoidance of Exposure to pets. It is recommended that pets should be 
removed from the home if a person has allergic symptoms. 
 Minimizing exposure to house dust mite by replacing carpets with 
floor boards and using mite impermeable bedding.  
 Reduction of fungal exposure and elimination of cockroaches.
[16] 
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 Homoeopathic approach:  
drug disease some group of condition which simulate real chronic  disease  
occur in persons ,  
dissipation 
  
  
heir health  by over exertion  of body and mind  
ng in  constant state of worry...in this state of ill health is bring 
upon by removing these things .. Aphorism 210-230 in mental disease 
management master told that almost all mental and emotional  disease are 
corporeal  disease in which symptoms of derangement  and disoistion each of 
them increased while corporeal symptoms are decline .Eg suppression of lung 
disease leads insanity… 
Aphorism 38 teach about suppression …suppression of skin disease 
may leads to lung disease. According to all these points we treat patient as a 
whole depend upon totality, dynamic medicine which erradicate tedency of 
hereditary also.
.[6] [26], [28] 
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RELAVENT RESEARCH STUDIES IN BRONCHIAL ASTHMA: 
According to” asthma call  back survey prevalence of disease among age”, 
adolescence group are above 16 was high in percentage.Under age of 1 which one 
exposure to bronchial allergy, respiratory infection, broncho pneumonia had more 
focus of respiratory BA in adolacence have higher intencity
.[30]
 
In  the Study of  Sex difference in bronchial asthma among 8 states in USA 
by RHODES MOORMAN  in” air pollution and respiratory health branch, division of 
environmental health effects and hazard” , centre of disease controle and prevention 
in atlando  , study concluded that lifetime and current asthma prevalence are higher in  
females, childhood asthma are reported more often in males in the journal of Asthma 
volume 42 , 2005 issue 9
.[31]
 
               In the lung disease news.com , skin disease atopic dermatitis and 
susceptibility to allergies have increase risk of asthma, study found that  year old 
infants who have skin disease known as atopic dermatitis are 7 times more likely to 
developed ASTHMA which is found in the Canadian healthy infants longitudinal 
developmental child study by Malcolm sears , one of professor in firestone institute of 
respiratory health at st Joseph healthcare , Hamilton
.[29]
               
             In American journal of preventive medicine , this study shows that genetic 
and hereditary exposure is risk factors for childhood asthma and atopic skin disease , 
need to preventive care to reduce exposure to environmental factors which is 
triggering  BA. Like this study in our study also had family history of BA for about 
45% especially in female groups.
[30] 
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                                            MATERIALS AND METHODS: 
 STUDY SETTING: This study is designed to evaluate and compare the effectiveness of 
lung volume capacity before and after homeopathic constitutional remedy in asthma 
tested by spirometry . The study will be carried out at Out Patient Department (OPD) and 
Rural health centre (RHC) and In Patient Department (IPD)   at Sarada Krishna 
Homoeopathic Medical College and Hospital.  
SELECTION OF SAMPLES:         Sample Size: 30 cases      
Sampling Technique: Random sampling  
 STUDY DESIGN:            Cohort study  
DATA COLLECTION  
Medicine Prescribed  
Pre test/ Before  Medicine  
Post test /After Homeopathic Medicine  
PATIENT ALLOCATION:  
From the Random Number Table:  
-30 number given to Patient undergo  spirometry  before medication  he/ she will be 
administering  homeo remedy he/ she will be allocated into post test. This allocation was 
continued till last patient.  
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INCLUSION CRITERIA:   
 
  
 
intrinsic factors.  
assessment in part of rehabilitation programs . 
EXCLUSION CRITERIA:[12] 
 o Recent myocardial infarction on just or one month duration /above 35 age first time 
episode of dyspnea 
 o Recent stroke /unstable angina o Uncontrolled hypertension o Recent eye /abdominal 
surgery o H/O hemoptysis 
 o Pnemothorax/ thoracic aortic anurysm  
o  Smoke prior 24 hours   
 METHODOLOGY:     Total sample of 30 patients are selected from the Out Patient 
Department, In Patient Department, RHC department of  Sarada Krishna Homoeopathic 
Medical College  Based on inclusive criteria. The patient will be categorized 1-30 before 
treatment, 1A -30A After treatment underwent spirometry.  
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OBSERVATION AND FOLLOWUP:    The detailed case history is taken and it will be 
recorded in a pre-structured case format.  Patient diagnosed based on their symptoms like 
cough, wheezing, chest tightness, dyspnea, allergic, occupational, hereditary criteria. 
Basic routine investigation will do if necessary.Exclusive criteria is kept on mind while 
selection of the patients for spirometry. Before doing spiometry height , weight, age and 
smoking duration is considered. Ask the patient to get normal breathing, if needed nose 
clip may given. Followed by deep breath, tight close mouth around clip, than ask to 
exhale forcefully. Repeat the procedure 3 times best one is selected for record. Based on 
the forceful expiratory volume, obstruction on lung will be classified in to normal, mild 
obstructive ,moderate obstructive and severe obstructive . After complete case taking as 
per guidelines of Master hahnemann, analysis,evalation followed by  totality of case. 
Correct similimam to be selected by use of appropriate repertory based on totality of case 
.Selection of dose is based on susceptibility of patient  and stage of disease.After giving 
costitutional dynamic homeopathic remedy ,2-4 weeks followed by correct diet advice 
,physical restriction, respiratory therapy,stress management and cessation from 
smoking,allergens,hazards  of occupation once again repeated the spirometry as like 
before to compare the changes in obstructive airway lesion and improvement of forced 
volume capacity where it is more than 12 % that is 200 ml will signifies good 
improvement of lung volume after our homeopathic constitutional remedy which is equal 
and higher efficacy than corticosteroid (ICS) like other conventional treatment which is 
unsafe,costly,dependency treatment. 
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–Case taking   + Spirometr
Group B -  After  homeopathy  medicine( 2-
Improvement assesed by vitalograph spirometry reference scale .  
 SELE
 
-  
remedies for  bronchial asthma  
OUTCOME ASSESSMENT:  Depend upon  VITAL CAPACITY (VC)/PEAK 
EXPIRATORY FLOW RATE (PEFR)/FORCED EXPIRATORY VOLUME (FEV1)     
– -
79%   Predicted  - -59%    Predicted  - MODERATE 
- SEVERE OBSTRUCTION  After 
medication if there is changes in FEV1 about 12% indicate good improvement after given 
medication .  
DATACOLLECTION:                                                                                                                          
 
 STATISTICAL TECHNIQUES & DATA ANALYSIS: Pre-test and post-test assessment 
will be done.  Hypothesis will be analyzed by students  paired “t” test will be used to 
compare between the groups. Data will be represented by charts and graphs. Sample will 
be analysed based on two way ANOVA. 
5.0. OBSERVATIONS AND RESULTS 
 
A sample of 30 cases from the Out Patient Department and In Patient 
Department of Sarada Krishna Homoeopathic Medical College Hospital 
were selected for the study and divided into two groups A and B. All the 
30 cases were followed up for a period of six months. These cases were 
subjected to statistical study. The following tables reveal the observations 
and results of this study. 
 
TAB NO 1: DISTRIBUTION OF CASES BASED ON AGE 
 
 
AGE GROUP 
 
MALE 
 
FEMALE 
 
15-30 
 
2 
 
2 
 
30-45 
 
5 
 
7 
 
45-60 
 
4 
 
10 
 
 
 
From the above chart, it is inferred that maximum number of cases are 
attained between the age group above 45 years and out of that 10 cases are 
females , 5 male. Under the age group 30-40, 7 females ; 3 male patients. 
Under the age group 20-30, 2 females  and 2 males . 
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 MALE 
30 
 
  
TAB NO .3: DISTRIBUTION BASED ON FAMILY HISTORY 
 
 
With family 
history 
Without family 
history 
Male            4 7 
Female 11 8 
 
 
 
From the above chart, it is clear that majority of the patients with Bronchial asthma in 
both groups shows a family history of Asthma both Maternal as well as Paternal 
origin. 
 
TABLE NO.4: DISTRIBUTION BASED ON PAST HISTORY 
 
 
 
With past H/O 
skin disorder 
Without  past 
H/O skin 
disorder 
Male 4 7 
female 10 9 
 
 
0 
5 
10 
15 
With family 
history 
Without family 
history 
DISTRIBUTION OF CASE BASED 
ON FAMILY HISTORY 
Male 
Female 
31 
 
 
 
From the above chart, it is inferred that majority of the patients show a 
positive history of dermatitis, psoriasis, eczema followed by asthmatic attack. 
Layers of suppression of skin disease enter into vital organ. 
 
TABLE NO 5: DISTRIBUTION BASED ON MEDICINE 
PRESCRIBED 
 
0 
2 
4 
6 
8 
10 
With past H/O skin 
disorder 
Without  past H/O 
skin disorder 
BA PREVALENCE IN SUPPRESSION 
OF SKIN DISEASE 
Male 
female 
MEDICINES NUMBERS OF CASE 
ARS ALB 11 
PULS 5 
NATRUM SULPH 3 
LYCOPODIUM 2 
IPECAC 1 
HEPARSULPH 1 
ANTITART 1 
RHUSTOX 1 
IGNATIA 1 
BRYONIA 1 
PHOSPORUS 1 
IPECAC 1 
GRAND TOTAL 30 
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From above chart most of the bronchial asthma cases are to be well response 
by Arsanicum album constitutionally, puls, natrum sulph, lycopodium, ipecach, 
ignatia, rhustox, antitart, phosphorus and bryonia. Most of the remedy given in 50 
millesimal potency in frequent doses act well than dry doses.  
 
TABLE NO 6: OBSTRUCTIVE FACTORS FOR ASTHMA: 
    
Obstructive factors MALE FEMALE 
   Cold and dust exposure 5 15 
   Cold exposure 8 11 
   Cold in general 6 12 
   Cold in general and dust exposure 3 10 
   Dust and cold exposure 4 17 
   Dust exposure 8 9 
   Smoke and cold exposure 5 0 
   Smoke and dust exposure 4 0 
   Smoke exposure 5 4 
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1 
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IPECAC 
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IGNATIA 
BRYONIA 
PHOSPORUS 
IPECAC 
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REMEDIES 
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From above study cold exposure and dust have most obstructive factors for 
BA about 60%, smoking and smoke exposure had 30% of obstructive values  in this 
study. 
 
 
TABLE NO 7: DISTRIBUTION OF CASES BASED ON OCCUPATION 
TABLE 
OCCUPATION TOTAL NO OF 
CASES 
PERCENTAGE 
Housewives 18 60 
Students 3 10 
Private Employees 7 23.33 
Govt.Servants 2 6.66 
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From above study we could obsorbed that home maker which one exposure to smoke 
, dust have high risk in prevalence of BA about 55% compare with other occupational 
exposures. 
 
TABLE NO 8: SHOWS THE DISTRIBUTION OF CASES ACCORDING TO 
SYMPTOMS OF BRONCHIAL ASTHMA 
Symptoms Of 
Bronchial Asthma 
No. Of 
Patients 
Percentage 
Breathing Difficulty 30 100 
Cough 30 100 
Wheezing 30 100 
Shortness Of  Breath 30 100 
Mucous 20 66.66 
Chest Pain 14 46.66 
Weight On Chest 15 50 
 
 
 
0 5 10 15 20 
Housewives 
Students 
Private Employees 
Govt.Servants 
18 
3 
7 
2 
NO OF CASES 
O
C
C
U
P
A
T
IO
N
 
DISTRIBUTION OF CASES ACCORDING TO 
OCCUPATION 
0 
20 
40 
N
O
 O
F 
C
A
SE
S 
DISTRIBUTION OF CASES WITH 
SYMPTOMS OF BRONCHIAL ASTHMA 
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DISTRIBUTION BASED ON FEV1 VALUES 
TABLE NO 9: 
 FEV1 VALUES OF PATIENTS BEFORE AND AFTER TREATMENT 
 
SL 
NO BEFORE TREATMENT AFTER TREATMENT 
1 1.9 2.8 
2 0.58 1.09 
3 1.01 2.11 
4 1.6 2.2 
5 1.78 3.15 
6 0.8 1.7 
7 0.58 1.77 
8 1.5 2.07 
9 1.7 2.43 
10 0.93 3.3 
11 0.58 1.77 
12 0.82 1.62 
13 1.9 2.26 
14 1.53 1.64 
15 1.5 2.42 
16 1.5 1.76 
17 0.5 1.6 
18 1.5 2.49 
19 1.12 2.29 
20 0.86 2.1 
21 1.18 2.07 
22 0.8 1.9 
23 0.64 1.5 
24 0.6 1.5 
25 1.18 2.01 
26 0.5 1.18 
27 2.31 3.4 
28 1.5 2.01 
29 1.7 2.9 
30 0.6 1.7 
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TABLE NO 9: PREDICTIVE % OF SPIROMETRY VALUE  BEFORE AND 
AFTER TREATMENT 
CASE 
BEFORE 
TREATMENT  
(%) 
AFTER 
TREATMENT 
% 
1 45 65 
2 72 88 
3 55 85 
4 65 88 
5 70 87 
6 60 75 
7 65 80 
8 69 90 
9 78 88 
10 55 78 
11 76 91 
12 55 75 
13 50 76 
14 62 85 
15 45 55 
16 48 70 
17 25 36 
18 65 77 
19 50 72 
20 60 76 
21 75 81 
22 65 82 
23 60 72 
24 50 62 
25 73 85 
26 66 78 
27 80 98 
28 49 52 
28 70 93 
30 72 85 
0 
2 
4 
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 
FEV1 VALUE BEFORE AND AFTER 
TREATMENT BEFORE … AFTER … 
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From this study we could get that above data that is before and after FEV 1 & 
PREDICTIVE % shows that about 75% case had good positive changes in expiratory 
values after treatment, 10% have equal values and 15 % had negative , no changes in 
lung volumes even after that effective treatment, its may due to some continuous 
exposure to smoke and dust in low economic status in rural residence and also due to 
difficulty in spirometry mouthpiece holding error to be absorbed 
 
 
          TYPES OF ASTHMA BEFORE AND AFTER TREATMENT 
TYPES BEFORE TREATMENT AFTER TREATMENT 
MILD 7 5 
MODERATE 10 6 
SEVERE 9 2 
PERSISTANT 4 2 
NORMAL 0 15 
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  According to ATS classification of bronchial asthma , prognosis of disease 
before and after treatment classified as normal, mild, moderate, severe and persistant. 
Mild type improved as 7%- 5%, moderate as 10%-6%, severe as 9%- 2%, persistant 
from 4%-2%, 15% became normal as a whole study of 30 patients from this research
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STATISTICAL ANALYSIS 
SL.NO BEFORE AFTER d=X-Y  -     -  )2 
1 45 65       -20 475 225625 
2 72 88 -16 479 229441 
3 55 85 -30 465 216225 
4 65 88 -23 472 222784 
5 70 87 -17 478 228484 
6 60 75 -15 480 230400 
7 65 80 -15 480 230400 
8 69 90 -21 474 224676 
9 78 88 -10 485 235225 
10 55 78 -23 472 222784 
11 76 91 -15 480 230400 
12 55 75 -20 475 225625 
13 50 76 -26 469 219961 
14 62 85 -23 472 222784 
15 45 55 -10 485 235225 
16 48 70 -22 473 223729 
17 25 36 -11 484 234256 
18 65 77 -12 483 233289 
19 50 72 -22 473 223729 
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20 60 76 -16 479 229441 
21 75 81 -6 489 239121 
22 65 82 -17 478 228484 
23 60 72 -12 483 233289 
24 50 62 -12 483 233289 
25 73 85 -12 483 233289 
26 66 78 -12 483 233289 
27 80 98 -18 477 227529 
28 49 52 -3 492 242064 
29 70 93 -23 472 222784 
30 72 85 -13 482 232324 
TOTAL   ∑  =-
495  
      ∑  -  )2  = 
686994 
 
X= Score before treatment 
Y= Score after treatment 
d= Difference between before and after score 
A. Null hypothesis 
There is no difference between the scores taken before and after the 
Homoeopathic treatment. 
B. Alternate hypothesis 
There is difference between the scores taken before and after the 
Homoeopathic treatment. 
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C. Standard error of the mean difference 
The mean of the differences,    = Σ d/n 
                                                  =-495/30 
    =-16.5 
The estimate of population standard deviation is given by, 
SD =                   
      =                   
       =              
       = 486.7182 
 Standard error, (S.E) = S.D /    = 486.7182/     = 88.8621 
 Clinical ratio, t =  
  
     
 
   = 16.5/88.8621 
   = 14.82 
T test: paired sample test for two means 
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t-Test: Paired Two Sample for Means 
     AFTER BEFORE 
Mean 77.500 61.000 
Variance 175.638 150.621 
Observations 30.000 30.000 
Pearson Correlation 0.889 
Hypothesized Mean Difference 0.0001 
df 29.000 
t Stat 14.826 
P(T<=t) one-tail 0.0001 
t Critical one-tail 1.699 
P(T<=t) two-tail 0.000 
t Critical two-tail 2.045 
 
Comparison with tabled value:  
This critical ratio, t follows a distribution with n-1 degrees of freedom. The tabled t 
value at 5% significance level is 2.045 and 1% level is 2.756 for 29 degrees of 
freedom. Since the calculated value 14.82 is greater than the tabled t value at 5% and 
1% level, the null hypothesis is rejected.  
Inference 
This study shows significant reduction in the FEV1 PREDICTIVE % scores after 
giving the homoeopathic medicines for management of bronchial asthma. Therefore, 
homoeopathic medicines are effective in managing the pain of bronchial asthma. 
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DISCUSSION 
The study was conducted on Random selection of 30 cases of patient Symptoms from the OPD, IPD 
and RHC’s of SKHMC Hospital. The case details are recorded in a standardized pre structured case 
format of Sarada Krishna Homoeopathic Medical College. To study the effectiveness of 
Homoeopathic remedy which changes in lung volume especialy FEV 1 in the condition of bronchial 
asthma patient evidenced by spirometry. 
Patient selected for the study based on inclusive criteria.  Complete chronic case taking took under the 
guidance of Dr.Hanemann  , which one explained in the aphorism of 83-104. By this could be 
analysed the past history , familial and hereditary background, miasmatic prevalence of disease. By 
the intensity of symptoms based,  totality formed and constitutional remedy was selected .Patient 
adviced to do spirometry before administering remedy .Acute severe asthma is excluded. SPO2 level 
less than 85 % of the patients are excluded. Based on totality constitutional remedy was selected, 
based on susceptibility correct potency  was selected and medicine given for a week. Followup taken 
in a week and progress uptained till 6 month. Patient adviced to took spirometry once again to study 
the lung volume changes after end of treatment. In-between symptoms severity, episode of recurrence 
of disease to be analysed after expose to some exiting causes and maintaining causes to be try to 
avoided.  . 
  
AGE: According to” asthma call  back survey prevalence of disease among age”adolescence 
group are above 16 was high in percentage.Under age of 1 which one exposure to bronchial allergy, 
respiratory infection, broncho pneumonia had more focus of respiratory BA in adolacence have higher 
intencity
[30]
. In this way in our study maximum number of cases under the age of 15-30 both gender 
equal in affected, 30-45 yrs of age  group had 15% male 35 % female. Above 45 age group 60% are 
female in the total 30 cases of study.   
SEX:  In  the Study of  Sex difference in bronchial asthma among 8 states in USA by RHODES 
MOORMAN  in” air pollution and respiratory health branch, division of environmental health effects 
and hazard” , centre of disease controle and prevention in atlando  , study concluded that lifetime and 
current asthma prevalence are higher in  females, childhood asthma are reported more often in males 
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in the journal of Asthma volume 42 , 2005 issue 9
.[31]
 Like this study , in our study among 30 cases 
70% are female were affected by asthma which is higher prevalence than male under this study.  
 Skin disease relavence in BA: In the lung disease news.com , skin disease atopic dermatitis and 
susceptibility to allergies have increase risk of asthma, study found that  year old infants who have 
skin disease known as atopic dermatitis are 7 times more likely to developed ASTHMA which is 
found in the Canadian healthy infants longitudinal developmental child study by Malcolm sears , one 
of professor in firestone institute of respiratory health at st Joseph healthcare , Hamilton. Based on this 
study likewise in our study group also have 50% of previous episode of atopic dermatitis and 
suppression of this leads development  asthma in adolescence stage is proved evidence From the 
above study, it is inferred that majority of the patients 50 %show a positive history of dermatitis, 
psoriasis, eczema followed by asthmatic attack. Layers of suppression of skin disease enter into vital 
organ 
FAMILY HISTORY OF BA:  
               In American journal of preventive medicine , this study shows that genetic and hereditary 
exposure is risk factors for childhood asthma and atopic skin disease , need to preventive care to 
reduce exposure to environmental factors which is triggering  BA. Like this study in our study also 
had family history of BA for about 45% especially in female groups. From the above study, it is clear 
that majority of the patients with Bronchial asthma in both groups shows a family history of Asthma 
both Maternal as well as Paternal origin. 
 
ACOS: Asthma and COPD Overlapping syndrome.Modifiable risk factors for asthma and COPD 
overlap encouraging healthy living, , issue nov 01, 2018 .In the month issue ofAnnals American 
Thoraxic Soceity pg-1304-1310 , shows that asthma ans COPD overlap is burden of disease which 
leads frequent exacerbation rate and higher morbidity rate either by asthma or COPD.42% among 
women have developed co –occurance of BA and COPD also. Like this someother obstructive factors 
are Ageing, > 5 pack year smoking history, unemployment, higher body mass, lower educational, 
rural residence are evidenced in our study. From above study we could obsorbed that home maker 
which one exposure to smoke , dust have high risk in prevalence of BA about 55% compare with 
other occupational exposures
.[30] 
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MANAGEMENT OF BA:  life style modification , avoiding risk factors, prevention of disease 
which one exposure to family history and  atopic skin disease with constitutional remedy will gave 
better improvement to the patient and reduce recurrence also. Arsanicum album , natrum sulph, 
pulsatilla , lycopodium  gave good results in 50% cases. Remaining cases covered by phosphorus, 
bryonia, rhustox, antimonium tart and ipecac .Many of the case 55%have good prognosis while 
administered in 50 millesemal potency in water dose in frequent intravel had higher effect than the dry 
dose. 
SPIROMETRY :  One of lung function test which is shows the forced expiratory volume rate in one 
mint of the patient, shows vital capacity, total lung capacity. By means of ATS value pre and post 
FEV1 AND PREDICTIVE % are absorbed score to be calculated for statistical T value which shows . 
in this study patient had difficulty in user defect which also may affect the lung volume changes may 
produce error in the value. Cost of this device may difficult to advice all those patient. 15% of case 
among this study shows negative prognosis , 10% have equal values and 75% are  have good 
prognosis of FEV 1 changes in lung volume capacity which is improved from severe obstructive to 
moderate , mild obstruction . Grade of dyspnea IV also  changed to grade 2 . Intensity of symptoms 
are reduced. 
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8.0 LIMITATIONS 
 
 
 A study for a longer period and larger population will have been 
more useful.

 Some good cases could not be included in this study because of 
their discontinuity during the study period.

 In some cases, necessary information’s were lacking and the study 
was based on the available data.

 There were no standard studies done in Homoeopathy to compare or 
take guidance from therefore some errors are expected.

 Full pulmonary function tests using spirometry, serum IgE and skin 
prick tests are not done in this study due to the lack of availability 
and patients’ unaffordability (Ethical standards).
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8.1 RECOMMENDATIONS. 

 Extended time of research would provide better results.  
 Universal standardized scale can be used, so that evaluation of 
outcome of the study would become precise. 
 
 Full pulmonary function tests, IgE and skin prick tests if done 
during the study would have provided valuable results 
regarding the type of asthma and degree of bronchoconstriction. 
 
 
 Comparative study between other treatments and homoeopathy 
is needed to prove homoeopathy prior to them. 
 
 Comparative study needed between conventional treatment and 
homoeopathy. 
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                                                        9.0. CONCLUSION  
There were a total number of 30 cases selected randomly from the patients based on 
inclusive criteria who attended the Outpatient as well as Inpatient Departments of Sarada 
Krishna Homoeopathic Medical College Hospital and rural health centre. Chronic case 
taking followed by repatriation based on totality, constitutional remedy is selected. Pre 
and post spirometry values are observed after 4-6 weeks of followup.  Conclusions were 
made after statistical analysis of patients with Bronchial Asthma. The following 
conclusions were drawn from the study as follows: 
 The prevalence of bronchial asthma is more in females than males. 
 Females in the age group 35-45 years have more prevalence. 
 Most of the patients with bronchial asthma are housewives who are constantly 
exposed to biomass fuel exhaust house hold smoke and dust. 
 Major causative factor for Bronchial asthma is dust exposure followed by cold 
and smoke exposure. 
 Most of the patients 60-70 % who had asthma had strong past history of 
suppression of skin disease by other conventional treatment and external ointments. 
 From this study, it was understood  that most of the patients have a strong family 
history of asthma, which has a strong genetic predisposition. 
 In BA, uncontrolled smoking, diet, exposure to dust , occupational  and 
psychological stress comes under the category of exiting cause. So according to 
our pioneer Master Hahnemann, “the exciting cause must be removed in order to 
attain rapid gentle and permanent cure”. 
 Arsenicum Album is found to be the most utilized remedy followed by 
lycopodium, sulphur, Pulsatilla, Natrum Sulph and phosphorus. 
 By means of observation, it shows that indicated medicine act well in millesimal 
potency in repeated doses in BA. 
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 After end of this study, its clear about that some patient have difficulty in utilize 
mouthpiece while doing spirometry which leads some error in the report value , long 
expiration leads difficulty in complete the procedure. 
 FEV markedly improved after administered our homoeopathic remedy in patients 
of  BA. 
 The Homoeopathic medicines given along with life style modification is found to 
be highly efficacious in management and treatment of Bronchial Asthma, it reduced 
recurrent of episode of attack and severe complication, reduce the dependency of 
inhalers’ also. 
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10.0 SUMMARY 
 
 
A sample of 30 cases from the patients who visited Sarada Krishna Homoeopathic 
Medical College Hospital OPD, RHC and IPD were selected randomly as per the 
inclusion criteria. The samples for the study constituted of patients who presented with 
the common symptoms of bronchial asthma. Prescription was based on symptom 
similarity. The cases were followed up for a period of six months. On the basis of before 
treatment and after treatment scores obtained from spirometry FEV1 value,FEV1/FVC 
ratio as well as reduction or complete absence of symptoms, recurrence of episode. The 
study was subjected to statistical analysis of “paired t test” and result where obtained 
from the observation. This study provides an evidence to show that there is a significant 
reduction in the disease progression, with improvement of lung volume capacity after 
administering Homoeopathic Medicines. 
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APPENDIX-I 
 
GLOSSARY 
 
1. Constitution- The physical body and mental temperament that is 
expressive of the natural traits and predisposition of the individual. 
 
2. Concomitant- Refers to symptoms that happen at the same time as the 
chief complaint. 
 
3. Aggravation (Homoeopathic aggravation, symbolized by <) A situation in 
which the patient feels worse from or symptoms are increased by a 
remedy. 
 
4. Amelioration- (Homoeopathic amelioration, symbolized by >) an 
improvement of the patient or decrease in symptoms. 
 
5. Materia Medica- Means materials of medicine in Latin. A reference that 
lists the curative indications and therapeutic actions of homoeopathic 
medicines. 
 
6. Proving- The most accurate method of ascertaining the action of 
medicines on human health. Medicines are administered to healthy people 
to discover the symptoms they are capable of producing and thereby able 
to cure. 
 
7. Modality- A condition that makes a person or their symptoms better or 
worse. 
 
8. Doctrine of Signatures- The concept that any organic substance carries 
within itself the likeness of some organ or part of the human economy, as 
a sign that this particular substance was applicable to disturbances of that 
organ. 
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Appendix - II 
 
“Case records are our valuable asset” 
 
SARADA KRISHNA 
 
HOMOEOPATHIC MEDICAL COLLEGE & HOSPITAL 
 
KULASEKHARAM, KANYAKUMARI DIST, TAMIL NADU- 629161  
 
 
 
 
 
O.P. No: 
 
 
 
 
CHRONIC CASE RECORD 
…………………… Unit…………. 
 
 
 
 
 
 
 
Date: ………. 
 
 
Name: 
 
…………………………………………………………………………………............. 
 
Age: ………Years, Sex: ……. Religion: …………. Occupation: …………………… 
 
Address: ………………………………………………… …………………………… 
 
…………………………………………………..…………………………………….. 
 
Phone No (Land): ……………………………………. (Mobile): ……………………  
 
 
Sl.No. Dt. of Admn. Dt. of Disch  Dt. of Review I.P. No. Ward Bed No. Remarks 
 
1 
 
2 
 
3 
 
4 
 
5  
 
 
 
FINAL DIAGNOSIS:  
 
Homoeopathic 
 
Disease  
 
 
 
 
RESULT: Cured Relieved Referred Otherwise Expired 
      
 
 
 54 
 
 
1. INITIAL PRESENTATION OF ILLNESS   
PATIENT’S NARRATION (in the very 
Expressions used by him / she) &                                                     PHYSICIAN’S OBSERVATION  
PHYSICIAN’S INTERROGATION  
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2.PRESENTING COMPLAINTS  
 
 
    LOCATION      SENSATION&    MODALITIES       Accompanying               
&DURATION      PATHOLOGY                                       Symptoms  
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3. HISTORY OF PRESENTING ILLNESS & TREATMENT  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. HISTORY OF PAST ILLNESS & TREATMENT ADOPTED  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. HISTORY OF FAMILY ILLNESS:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. PERSONAL HISTORY:  
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7. LIFE SPACE INVESTIGATION:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8. PSYCHIC FEATURES:  
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9. PHYSICAL FEATURES:  
 
 
 
A. APPEARANCE 
 
 
 
 
 
 
 
 
 
 
B.REGIONAL 
 
 
 
 
 
 
 
 
 
 
C.GENERALS 
 
 
 
 
 
 
 
 
 
 
D.PHYSICAL EXAMINATION   
i) General   
Jaundice: Anaemia: Oedema: 
Cyanosis: Clubbing: Lymphadenopathy: 
Skin colour: Discolouration: Skin eruption: 
Height: Weight: B.M.I: 
Pulse rate: Resp.rate: Temp: 
B.P:   
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ii) Systemic 
 
1. Respiratory System: 
 
 
 
 
 
 
2. Cardio Vascular System: 
 
 
 
 
 
 
 
3. Gastro Intestinal System: 
 
 
 
 
 
4. Urogenital System: 
 
 
 
 
 
5. Musculo-skeletal System: 
 
 
 
 
 
 
6. Central Nervous System: 
 
 
 
 
 
7. Skin: 
 
 
 
 
 
8. Endocrine: 
 
 
 
 
 
9. Eye/ENT: 
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10. MENSTRUAL HISTORY:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11. OBSTETRICAL HISTORY:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12. LABORATORY FINDINGS:  
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13. ANALYSIS & DIAGNOSIS OF DISEASE: 
 
A. Provisional Diagnosis: 
 
 
B. Differential Diagnosis:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. Final Diagnosis (Disease)  
 
 
 
 
14. DIAGNOSIS OF THE PATIENT  
 
A. Analysis: 
 
 
 
 
 
 
 
 
B. Evaluation of Symptoms/Totality of Symptoms: 
 
 
 
 
 
 
 
 
 
C. Miasmatic Expressions: 
 
 
 
 
D. Repertorial Totality: 
 
 
 
 
 
E. Final Diagnosis (Homoeopathic): 
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15. MANAGEMENT & TREATMENT 
 
 
 
A. Plan of Treatment: 
 
 
 
 
 
 
B. General/Surgical/Accessory: 
 
 
 
 
 
 
C. Restrictions (Diet, Regimen etc):  
 
Disease Medicinal 
  
  
 
 
D. Medicinal: First Prescription: 
 
 
 
BASIS OF SELECTION 
 
i) Medicine: 
 
 
 
 
 
 
ii) Potency: 
 
 
 
 
 
 
 
 
iii) Dose: 
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16. PROGRESS & FOLLOW UP  
 
DATE SYMPTOM CHANGES INFERENCE PRESCRIPTION 
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SCALE CHART: 
OUTCOME ASSESSMENT:  
                          Depend upon VITAL CAPACITY (VC)/PEAK EXPIRATORY FLOW 
RATE (PEFR)/FORCED EXPIRATORY VOLUME (FEV1)     Lung function is 
classified as, 
 –NORMAL 
 -79%   Predicted -MILD OBSTRUCTION 
  40-59%    Predicted  - MODERATE OBSTRUCTION  
- SEVERE OBSTRUCTION   
After medication if there is changes in FEV1 about 12% indicate good improvement after 
given medication.  
DATACOLLECTION:                                                                                                                          
By interview technique and observation 
   
 ation 
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APPENDIX VI 
 
 
CONSENT FORM 
 
INFORMATION FOR PARTICIPANTS OF THE STUDY 
 
 
 
 
 
1. Title of the project: “Clinical study on homeopathic management of bronchial asthma 
with reference to lung volume capacity using spirometry. 
2. Name of the investigator/guide : Dr. N. V. SUGATHAN MD, 
       Professor, 
       Department of Practice of medicine, 
       Sarada Krishna Homoeopathic Medical College, 
       Kulasekharam. 
3. Purpose of this project/ study: To study on homeopathic management of bronchial 
asthma with reference to lung volume capacity using spirometry. 
4. Procedure/methods of the study: Total sample of 30 patients are selected from the 
Out Patient Department, In Patient Department, RHC department of  Sarada Krishna 
Homoeopathic Medical College  Based on inclusive criteria. The patient will be 
categorized 1-30 before treatment, 1A -30A After treatment underwent spirometry .  
5.  Expected duration of the subject participation : 1 to 2 months with follow up  
6. The benefits to be expected from the research to the participant or to others and 
the post trial responsibilities of the investigator: The participant who takes part in 
this study are contributing towards the management of bronchial asthma by 
homeopathy without adverse effects. Through this study the participant get best quality 
of improvement in lung volume capacity by Homoeopathic treatment for their 
complaints tested by accurate lung function test called spirometry.   
7. Any risks expected from the study to the participant: For the treatment best 
selected Homoeopathic medicines will be given. So there will not be any adverse effect 
or risk because of the study. 
8. Maintenance of confidentiality of records: I will not disclose identity of the research 
participants at any time , during or after the study period or during publication. 
Securely store data documents in locked locations and Encrypt identifiable 
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computerized data. All information revealed by you will be kept as strictly 
confidential. 
9. Freedom to withdraw from the study at any time during the study period without 
the loss of benefits that the participant would otherwise be entitled : Your 
participation in the study is voluntary and you are free to refuse treatment or withdraw 
from the study at any time if you are not satisfied. 
 
10. Possible current and future uses of the biological material and of the data to be 
generated from the research and if the material is likely to be used for secondary 
purposes or would be shared with others, this should be mentioned : Future uses of 
the biological material and of the data to be generated from the research and if the 
material is likely to be used for secondary purposes or will be shared with others only 
with your consent. 
 
 
11. Address and telephone number of the investigator and co-investigator/guide : 
 
 
Investigator:    Dr.Ayyalammai M, P.G. Scholar,  
Department of Practice of medicine,  
Sarada Krishna homoeopathic medical college and hospital,              
Kulasekharam, Mobile no: 8056817022.  
Guide:              Dr. N. V. SUGATHAN, MD, 
                                                            Professor.  
Department of Practice of medicine, 
Sarada Krishna Homoeopathic Medical College, 
Kulasekharam. 
 
 
12. Signature of investigator: 
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                                           FORM  - 4   : CONSENT FORM (B) 
 
Participant consent form 
  
Informed Consent form to participate in a clinical trial 
 
Study Title: “Clinical study on homeopathic management of bronchial asthma with reference to 
lung volume capacity using spirometry”. 
 
Study Number:   
Subject’s Initials:                                  Subject’s Name: 
Date of birth/Age: 
Please initial 
                                                                                                                                  Box (Subject)  
 
 
i. I confirm that I have read and understood the information sheet dated                      [ ]  
___july 2017_______ for the above study and have had the opportunity to ask question.  
ii. I understood that my participation in the study is voluntary and that I am           [ ]      
free to withdraw at any time’ without giving any reason. Without my medical care or  
legal rights being affected.  
iii. I understand that the sponsor of the clinical trial,others working on the sponsor’s           [ ] 
behalf the Ethics Committee and the regulatory authorities will not need my permission 
to look at my health records both in respect of the current study and any further research  
that may be conducted in relation to it, even if I withdraw from the trial. I agree to this 
access. However, I understand that my identity will not be revealed in any information 
released to third parties or published.  
iv. I agree not to restrict the use of any data or result that arise from this study          [ ] 
Provided such a use only for scientific purpose(s)  
v. I agree to take part in the above study.  
 
Signature (or Thumb impression of the subject/legally acceptable 
Representative:___________________  
Date _______/________/___________  
Signatory’s Name: ________________  
Signature of the Investigator: ______________  
Study Investigator’s Name: Dr Ayyalammai.M  
Signature of the Witness______________ Date: _______/_________/_______  
Signature of the Witness _______________Date _______/__________/______ 
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Appendix - VII 
 
“Case records are our valuable asset” 
 
SARADA KRISHNA 
 
HOMOEOPATHIC MEDICAL COLLEGE & HOSPITAL 
 
KULASEKHARAM, KANYAKUMARI DIST, TAMIL NADU- 629161 
 
 
 
    CHRONIC CASE RECORD    
 
O.P. No: 325/17   Unit: III B   Date: 22.11.2016   
 
Name: Mrs. selvi          
 
    Age:48Years,  Sex: female 
Religion: 
christian  
Occupation: 
housewife  
 
           
 
Address: kattupuli,        
 
 Thuckalay.          
 
Phone No (Land): 04651-252875     (Mobile):   
 
FINAL DIAGNOSIS:          
 
          
 
Homoeopathic CHRONIC MIASMATIC DISEASE- SYCOSIS  
 
           
 
Disease  Bronchial asthma    
 
             
 
            
 
RESULT: Cured  Relieved  Referred  Otherwise Expired  
 
          
 
INITIAL PRESENTATION OF ILLNESS:    
 
      
 
 PATIENT’S NARRATION (in the very     
 
 expressions used by him / she) &   
PHYSICIAN’S OBSERVATION 
 
 
 PHYSICIAN’S INTERROGATION     
        
 
         
 
 The patient narrated that he has   
Dark complexion, well 
built, cooperative,     
 
Difficult in breathing, chest pain, cough, 
watery from nose, sneezing since 1 
week. Recurrent attack at cold climate 
  
 
 
Steady gait. 
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PRESENTING COMPLAINTS: 
 
LOCATION & SENSATION & MODALITIES ACCOMPANIMENTS 
DURATION PATHOLOGY   
Respiratory 
system 
 Difficulty in 
breathing 
<night, dust, 
exposure to cold Heaviness of chest 
chest burning pain <ascending stairs  
 
 
 
nose 
Watery from nose, 
sneezing <rising from seat Headache heaviness + 
Since 1 ½ yrs  
>rest 
> early morning, 
open air 
 
 
  
 
 
HISTORY OF PRESENTING ILLNESS & TREATMENT 
 
The patient complaints started as difficulty in breathing, chest tightness more since 10 
days , persist for about 1 ½ years. Aggravated at lying down, night, exposure to cold 
climate, dust with heaviness of chest. Burning pain in chest more at ascending stairs. 
No sweating, no palpitation. No vomiting. Waterying of nose since 15 days more at 
early morning, open air with heaviness of head present. . Had allopathic treatment  
temporary relief only.H/O dust allergy+ , no drug allergy, no relavent surgical history 
no H/O epistaxis, no fever, no history of weightloss. 
 
HISTORY OF PAST ILLNESS & TREATMENT ADOPTED 
 
                                Had dust allergy, no H/O HT,DM,PT,JAUNDICE, MUMPS. 
 
HISTORY OF FAMILY ILLNESS: 
 
H/O eczema to her mother had allopathic management.Father had 
hypertension.
 
PERSONAL HISTORY: 
 
Place of birth: kattupuli 
 
Religion: hindu 
 
 
 
 
Dwellings: Thuckalay 
 
occupation: housewife 
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Education: +2 
 
Economic status: Moderate 
Social status :Good 
 
Nutritional status:  Moderate 
 
Marital status: Married 
 
 
Yr. Of marriage: 24yrs 
 
 
Family status: Nuclear 
 
Father: Died 
 
 
Mother: Died 
 
 
Siblings: 2 
 
 
M:3 
 
 
F:3 
 
 
Children:2 
  
HABITS AND HOBBIES: 
 
Food: Non.veg 
 
Addictions: Tea 2cups/day 
 
Sleep: Good 
 
DOMESTIC RELATIONS: 
 
With family members: Good 
 
With other relatives: Good 
 
With neighbours/ friends/ colleagues: Good 
 
LIFE SPACE INVESTIGATION: 
 
The patient was born in a moderate family at thuckalay. His father was an business 
man and mother was an house wife. He had 1 brother and 1 sister. He studied upto 
BA.,BL. He got married at 24yrs of age. He had 2 children. His wife was died one 
month back so he is having grief about that. 
 
PSYCHIC FEATURES: 
 
Reserved 
 
Obstinate 
 
Easily angered for small things 
 
Grief about his wife’s death  
Increased sexual desire 
 
PHYSICAL FEATURES 
 
APPEARANCE: 
 
Dark complexion 
 
Moderate stature 
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Steady gait 
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REGIONAL: 
 
Blackish discoloration on right big toe 
 
 
GENERALS: 
 
Appetite: Normal 3times/day 
 
Thirst: Decreased 
 
Sleep: Disturbed 
 
Stool: Regular 
 
Urine: Normal 
 
Sweat: Increased over upper part of the body 
 
REACTION TO: 
 
Desires: cold season 
 
Aversion: Sweet 
 
Desires: Warm food & drinks 
 
Desires: Spicy foods, Alcohol 
 
Desires: Egg 
 
Desires: Fish 
 
 
 
PHYSICAL EXAMINATION 
 
i) General 
 
Jaundice: Not icteric 
 
 
Anaemia: Pallor present 
 
 
Oedema:  Nil 
 
 
Cyanosis: Nil 
 
 
Clubbing: Nil 
 
 
Lymphadenopathy: Nil 
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Skin colour: Dark discolouration: present on rt big toe 
 
 
Skin eruption: Nil 
 
 
Weight: 67.2kgs 
 
 
Pulse rate:88/min 
 
 
Resp.rate: 20/min 
 
 
Temp: Afebrile 
 
 
B.P: 130/70 mm of Hg 
 
 
 
 
ii) Systemic 
 
1. Respiratory System: 
 
Inspection: No DNS, No hypertrophied turbinate, No scar, No 
discoloration, No polyp, normal shape of the chest. 
 
Palpation: No local warmth, no tenderness , vocal fremitus equal on both 
sides, trachea normal in position, no tenderness over paranasal sinuses 
 
Percussion: Normal lung resonance heard 
 
Auscultation: bilateral wheeze heard all over auscultatory area+ 
 
 
 
2. Cardio Vascular System: 
 
Inspection: No scar, no discoloration, no pallor, no cyanosis 
 
Palpation: No local warmth, apex beat palpable at normal position 
 
Percussion: Normal cardiac dullness 
 
Auscultation: Normal heart sound S1, S2 heard tachy+ 
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LABORATORY FINDINGS: 
 
spirometry value: 
 
 
 
 
ANALYSIS & DIAGNOSIS OF DISEASE 
 
A. Provisional Diagnosis: 
 
 
BRONCHIAL ASTHMA 
 
 
B. Differential Diagnosi  
 CHRONIC BRONCHITIS 
BRONCHIECTASIS  
C. Final Diagnosis (Disease):  Bronchial asthma 
DIAGNOSIS OF THE PATIENT 
 
A. Analysis: 
 
COMMON UNCOMMON 
  
Difficulty in breathing  
   
 
>Warm drinks. 
 Reserved 
 Burning in chest 
 
 
Obstinate 
 
Cough dry Easily angered for small things,  
< night, lying  
Sneezing, watery nose < early 
morning 
 
 D: egg, fish, Warm food & 
>rest drinks, Spicy food 
 A: Sweets 
 D: Cold season 
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B.  Evaluation of Symptoms/Totality of Symptoms: 
 
 MENTAL GENERALS PHYSICAL  PARTICULARS 
  GENERALS   
 Reserved D: Egg, fish, warm  
Difficulty in breathing 
better warm drinks. 
< night , dust, cold seaon 
 Obstinate, Increased food& drinks, spicy   
  food,  Heart burn+ 
 Easily angered for small D: Cold season   
 things A: sweets  Sneezing < early morning 
    Headache heayness+ 
C. Miasmatic Expressions:    
     
 PSORA SYCOSIS  SYPHILIS 
     
 
Easily angered 
Sneezing > early 
morning, dust Reserved  
Tightness of chest 
Cold season 
  Obstinate  <night 
  
Heaviness of head 
 Cold season   
     
     
     
 
 
D. Non-Repertorial Totality: 
  
Difficulty in breathing  
  Cough dry 
< night, lying 
Sneezing, watery nose < early morning 
 
<rising from seat 
 
                             Spicy foods, Alcohol 
 
Easily angered, Increased Sexual Desire 
 
 
E. Final Diagnosis (Homoeopathic): 
 
CHRONIC MIASMATIC DISEASE – PSORA SYCOSIS 
 
 
MANAGEMENT & TREATMENT: 
 
A. Plan of Treatment: 
Medicinal management 
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B. General/Surgical/Accessory: 
 

 Take protein rich food in diet



C. Restrictions (Diet, Regimen etc): 
 
Disease Medicinal 
  
Avoid exposure to dust Avoid tea, coffee and other medicinal 
 stimulants 
  
 
 
D. Medicinal: 
First Prescription: 
 
Rx 
 
1. Ars alb 0/3/ 1D (HS) 
 
2. SD 1 – 1- 1. 
 
3. SG 3 – 3 -3. 
 
BASIS OF SELECTION 
 
i) Medicine: 
 
Difficulty in breathing,Easily angered,   
                             Desire spicy foods,   > night  , 
increased thirst    
   
 
 
ii) Potency: 
 
Based on the susceptibility of the patient 0/3 potency is selected 
 
iii) Dose: 
 
Based on the Homoeopathic principles single dose is given  
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PROGRESS & FOLLOW UP:  
 
 
 
DATE SYMPTOMS CHANGES INFERENCE PRESCRIPTION 
19.12.16  Difficulty in breathing reduced  Complaints Rx  
 Heart burn better reduced 1. Ars alb 0/3/1D(HS) 
 Sneezing reduced  2.SG 3- 3- 3 
 Generals: improved  3.SD 1- 1- 1 
 Sleep:disturbed    
 Stool:once in 2 days, hard    
 stool    
 
BP:100/70mm of hg 
RS- WHEEZE + Bilatral    
     
21.1.17  Complaints Rx  
 Difficulty in breathing better reduced 1. Ars alb 0/4/1D 
 <lying down  2. SG 3- 3- 3 
 Generals:  3. SD 1- 1- 1 
 Stool: difficult to pass    
 BP:110/70 mm of hg    
     
28.2.17 
Cough dry at night, difficulty in 
breathing, sneezing Complaints feels RX  
  feels better than better than 1. Ars alb 0/5/1D 
 before before but 2. SG 3- 3- 3 
 Generals: Good persists 3. SD 1- 1- 1 
 
BP: 110/70 mm of hg 
RS- CREPTS+    
     
22.4.17 Difficulty in breathing better Complaints feels Rx  
  better 1. PL/1D in 10 ml aqua 
    10gtt 2hrly 
   2. SG 3- 3- 3 
   3. SD 1- 1- 1 
 Generals: Good    
 
BP: 100/70 mm of hg 
RS- NVBS    
     
30.5.17 
Cough reduced , no difficulty in 
breathing, feel better Complaints feels Rx  
  better 1. PL/1D in 10 ml aqua 
 Generals: Good   10gtt 2hrly 
 BP: 110/70 mm of hg  2. SG 3- 3- 3 
 RS-  NVBS  3. SD 1- 1- 1 
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APPENDIX V 
MASTER CHART 
Sl 
N
o: 
Op no: Age  
In 
yrs 
Sex  Occupati
on  
Dwelling  Socio 
economic 
status 
Family 
history 
Diet  BMI Medicine  Potency  HbA1c 
R
e
su
lt
 
BT AT 
1 11925/8 29  M Teacher Urban  High  Mother, 
Father: 
Diabetic 
Non-veg 27 Phosphorus  200 5.9 4.8 
Im
p
ro
v
ed
 
2 9321/18 27  F Clerk  Rural  High  Father, 
mother: 
diabetic 
Non-veg 29 Lachesis  200 6.3 5.0 
Im
p
ro
v
ed
 
3 1951/18 50  M Security 
gaurd 
Rural  Middle  Father: 
diabetic 
Non-veg 25 Nux 
vomica 
30 6.2 5.3 
Im
p
ro
v
ed
 
4 3805/17 36  F Carpenter Rural  Middle  Mother, 
Brother: 
diabetic 
Veg  32.8 Sulphur  0/3 6.4 5.2 
Im
p
ro
v
ed
 
5 2664/18 47  F Housewif
e  
Rural  Middle  Mother: 
hypertensi
on 
Non-veg 37 Sulphur  200 6.4 5.2 
Im
p
ro
v
ed
 
6 336/18 52  M Business 
man 
Rural  Middle  Father: 
diabetic 
Non-veg 32 Sulphur  200 6.2 5.9 
Im
p
ro
v
ed
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7 5994/17 46  M Coolie  Rural  Low  nil Non-veg 30 Calcarea 
carb 
0/1 5.9 5.0 
Im
p
ro
v
ed
 
8 10230/1
7 
55  M Auditor  Urban  High  Father, 
Mother: 
diabetic 
Non-veg 31 Lycopodiu
m  
0/3 6.1 5.5 
Im
p
ro
v
ed
 
9 711/18 42  M Coolie Rural  Low  Father: 
diabetic 
Non-veg 23 Lycopodiu
m  
30 6.3 5.6 
Im
p
ro
v
ed
 
10 12646/8 52  M Driver  Rural  Middle  Mother, 
Fther, 
Brother: 
diabetic 
Non-veg 25 Fluoric 
acid 
200 6.2
4 
5.4 
Im
p
ro
v
ed
 
11 5775/17 53  M Business 
man 
Rural  High  Mother, 
father: 
diabetic 
Non-veg 24.8 Flouric 
acid 
30 6.4 5.1 
Im
p
ro
v
ed
 
12 9047/18 45  M Driver  Rural  Middle  Father: 
diabetic 
Non-veg 25 Lachesis  200 5.9 6.1 
N
o
t 
im
p
ro
v
ed
 
13 5984/18 51  M Mechanic
al 
engineer 
Rural  High  Mother, 
Father: 
diabetic 
Non-veg 22 Lycopodiu
m  
0/3 6.4 5.1 
Im
p
ro
v
ed
 
14 5696/18 48  F House 
Wife 
Rural Middle Father: 
Diabetic 
Non-veg 37 Pulsatilla 30 6.3 4.8 
Im
p
ro
v
ed
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15 5770/18 33  F House 
Wife 
Urban High Father, 
Mother, 
Brother: 
Diabetic 
Non-Veg 33.4 Phosphorus 0/1 6.4 5.2 
Im
p
ro
v
ed
 
16 6518/17 49  M Bank 
Employee 
Rural High Mother, 
Sister: 
Diabetic 
Non-Veg 27 Sulphur 0/1 6.2 5 
Im
p
ro
v
ed
 
17 1550/17 55  M Business 
Man 
Urban High Father: 
Diabetic 
Non-Veg 28 Natrum 
mur 
200 6.4 5.4 
Im
p
ro
v
ed
 
18 1879/18 55  M Business 
Man 
Rural Middle Father: 
Diabetic 
Non-Veg 31 Acid Phos 30 6 6.2 
N
o
t 
Im
p
ro
v
ed
 
19 10162/1
7 
39  F House 
Wife 
Rural Middle Mother, 
Brother: 
Diabetic 
Non-Veg 30 Calc Carb 200 6.2 4.9 
Im
p
ro
v
ed
 
20 4756/17 51  M Religious 
Person 
Rural Middle Father: 
Diabetic 
Non-Veg 32 Pulsatilla 200 6.4 5.2 
Im
p
ro
v
ed
 
21 62/17 45  M Coolie Rural Lower Father: 
Diabetic 
Non-Veg 28 Sulphur 30 6.1 5.4 
Im
p
ro
v
ed
 
22 8689/18 55  F Religious 
Person 
Rural Middle Mother : 
Diabetic 
Non-Veg 30 Sulphur  0/3 6.3 5.0 
Im
p
ro
v
ed
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23 8046/17 52  F House 
Wife 
Rural High Father: 
Diabetic 
Veg 29 Sulphur 200 5.9 4.7 
Im
p
ro
v
ed
 
24 675/18 51  F Teacher Rural Middle Father, 
Mother: 
Diabetic 
Non-Veg 32 Lycopodiu
m 
200 6 4.9 
Im
p
ro
v
ed
 
25 1686/18 48  M Govt. 
Employee 
Urban High Father: 
Diabetic 
Non-Veg 28 Sulphur 200 6.1 4.6 
Im
p
ro
v
ed
 
26 6026/17 47  F Teacher Rural High Mother, 
Brother: 
Diabetic 
Non-Veg 26 Staphysagri
a 
200 5.9 5.4 
Im
p
ro
v
ed
 
27 6527/18 43  F House 
Wife 
Rural Middle Mother: 
Diabetic 
Non-Veg 25 Nitric acid 30 6.4 5.1 
Im
p
ro
v
ed
 
28 4858/18 54  F House 
Wife 
Rural Middle Father, 
Mother, 
Sister: 
Diabetic 
Non-Veg 33 Nuxvom 200 6.2 6.6 
N
o
t 
Im
p
ro
v
ed
 
29 2176/18 36  M Teacher Rural High Mother, 
Uncle, 
Brother: 
Diabetic 
Non-Veg 32 Sulphur 0/3 6 4.7 
Im
p
ro
v
ed
 
30 2187/18 48  M Army Rural Middle Father: 
Diabetic 
Non-Veg 25 Arsalb 200 6.3 5.4 
Im
p
ro
v
ed
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DISTRIBUTION BASED ON FEV1 VALUE: 
 
FEV1 VALUES OF PATIENTS BEFORE AND AFTER TREATMENT 
SL 
NO BEFORE TREATMENT AFTER TREATMENT 
1 1.9 2.8 
2 0.58 1.09 
3 1.01 2.11 
4 1.6 2.2 
5 1.78 3.15 
6 0.8 1.7 
7 0.58 1.77 
8 1.5 2.07 
9 1.7 2.43 
10 0.93 3.3 
11 0.58 1.77 
12 0.82 1.62 
13 1.9 2.26 
14 1.53 1.64 
15 1.5 2.42 
16 1.5 1.76 
17 0.5 1.6 
18 1.5 2.49 
19 1.12 2.29 
20 0.86 2.1 
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21 1.18 2.07 
22 0.8 1.9 
23 0.64 1.5 
24 0.6 1.5 
25 1.18 2.01 
26 0.5 1.18 
27 2.31 3.4 
28 1.5 2.01 
29 1.7 2.9 
30 0.6 1.7 
 
 
PREDICTIVE % OF SPIROMETRY VALUE  BEFORE AND AFTER TREATMENT       
CASE BEFORE 
TREATMENT  (%) 
AFTER 
TREATMENT % 
1 45 65 
2 72 88 
3 55 85 
4 65 88 
5 70 87 
6 60 75 
7 65 80 
8 69 90 
9 78 88 
10 55 78 
11 76 91 
86 
 
12 55 75 
13 50 76 
14 62 85 
15 45 55 
16 48 70 
17 25 36 
18 65 77 
19 50 72 
20 60 76 
21 75 81 
22 65 82 
23 60 72 
24 50 62 
25 73 85 
26 66 78 
27 80 98 
28 49 52 
28 70 93 
30 72 85 
 
